CTI BioPharma

CTI was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. We strive to do business better than other biopharmaceutical companies. Better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. A willingness to push the limits to achieve challenging goals is the essential attribute that sets CTI employees apart.
Seattle, US
149 (est)

CTI BioPharma Locations

Seattle, US

CTI BioPharma Metrics

CTI BioPharma Summary

Founding Date


Market capitalization

$113 M

Closing share price


CTI BioPharma Market Value History

CTI BioPharma Company Life